Philip Lee
Chief Executive Officer presso GeneFab LLC
Patrimonio netto: 353 032 $ in data 31/03/2024
Posizioni attive di Philip Lee
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
GeneFab LLC
 GeneFab LLC BiotechnologyHealth Technology GeneFab LLC develops and commercializes genetic medicines. The American company was founded in 2023 and the CEO is Philip Lee. | Chief Executive Officer | 01/08/2023 | - |
Storia della carriera di Philip Lee
Precedenti posizioni note di Philip Lee
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| SENTI BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 01/01/2021 | 07/08/2023 |
| Founder | 01/01/2016 | 07/08/2023 | |
| President | 01/01/2016 | 01/01/2018 | |
| Treasurer | 01/01/2016 | 01/01/2020 | |
| MERCK KGAA | Chief Tech/Sci/R&D Officer | 01/01/2012 | 01/11/2014 |
| Corporate Officer/Principal | 01/11/2014 | 01/05/2016 | |
EMD Millipore Corp.
 EMD Millipore Corp. Miscellaneous Commercial ServicesCommercial Services EMD Millipore Corp. engages in the provision of laboratory materials, technologies, and services to the life science industry. The company was founded by Jack Bush in 1954 and is headquartered in Burlington, MA. | Chief Tech/Sci/R&D Officer | 01/01/2012 | 01/01/2014 |
| Corporate Officer/Principal | 01/01/2014 | 01/01/2016 | |
Cellasic Corp.
 Cellasic Corp. Packaged SoftwareTechnology Services Cellasic Corp. develops a microfluidic software platform for live cell analysis experiments. The American company was founded by Philip Lee. | Chief Executive Officer | 01/09/2004 | 01/04/2012 |
| Founder | 01/09/2004 | 01/04/2012 | |
Senti Sub I, Inc.
 Senti Sub I, Inc. BiotechnologyHealth Technology Senti Biosciences, Inc. develops novel therapeutics. It specializes in thetic biology, gene therapy and cell therapy. The company was founded by Timothy K. Lu, Wilson Wong, James J. Collins and Philip Lee in 2016 and is headquartered in South San Francisco, CA. | Director/Board Member | 01/07/2016 | 01/02/2018 |
| Chief Operating Officer | 01/02/2018 | 01/01/2021 | |
| Chief Tech/Sci/R&D Officer | 01/01/2021 | - | |
| Founder | 01/01/2016 | - | |
| President | 01/07/2016 | 01/02/2018 | |
| Treasurer | 01/02/2018 | 01/11/2020 |
Formazione di Philip Lee
| Massachusetts Institute of Technology | Undergraduate Degree |
| University of California, Berkeley | Doctorate Degree |
| The University of California, San Francisco | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 8 |
| Germania | 2 |
| 2 |
Posizioni
| Chief Tech/Sci/R&D Officer | 4 |
| Founder | 3 |
| President | 2 |
Settori
| Health Technology | 4 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| MERCK KGAA | Health Technology |
| Aziende private | 5 |
|---|---|
EMD Millipore Corp.
EMD Millipore Corp. Miscellaneous Commercial ServicesCommercial Services EMD Millipore Corp. engages in the provision of laboratory materials, technologies, and services to the life science industry. The company was founded by Jack Bush in 1954 and is headquartered in Burlington, MA. | Commercial Services |
Senti Sub I, Inc.
Senti Sub I, Inc. BiotechnologyHealth Technology Senti Biosciences, Inc. develops novel therapeutics. It specializes in thetic biology, gene therapy and cell therapy. The company was founded by Timothy K. Lu, Wilson Wong, James J. Collins and Philip Lee in 2016 and is headquartered in South San Francisco, CA. | Health Technology |
Cellasic Corp.
Cellasic Corp. Packaged SoftwareTechnology Services Cellasic Corp. develops a microfluidic software platform for live cell analysis experiments. The American company was founded by Philip Lee. | Technology Services |
| Senti Biosciences, Inc. | |
GeneFab LLC
GeneFab LLC BiotechnologyHealth Technology GeneFab LLC develops and commercializes genetic medicines. The American company was founded in 2023 and the CEO is Philip Lee. | Health Technology |
- Borsa valori
- Insiders
- Philip Lee
- Esperienza
